Breast cancer and ovarian cancer dominate among female oncological diseases. According to the world-leading research, of about 15% of such diseases emerge due to a genetic predisposition. BRCA test is a test for the genetic predisposition for oncological diseases of ovaries and mammary glands. The test helps to reveal the gene mutations that indicate the high risk of the oncological disease development. The mutation carriers have 50-80% higher risk of breast cancer and 15-40% higher risk of ovarian cancer.
The test is also used to choose the right treatment approach in case the tumor has already been revealed. The most effective method of treatment in case of oncological diseases caused by mutations of BRCA genes is the targeted therapy.
It is recommended to undergo the test for the women who have one or two close female relatives with one of these types of cancer.